Search Results - "Tighe, Kayla M."
-
1
Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine
Published in Frontiers in oncology (12-12-2022)“…The impact of asparaginases on plasma asparagine and glutamine is well established. However, the effect of asparaginases, particularly those derived from (also…”
Get full text
Journal Article -
2
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma
Published in Cancer & metabolism (30-06-2024)“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease without meaningful therapeutic options beyond the first salvage therapy. Targeting PDAC…”
Get full text
Journal Article -
3
Community-engaged basic science in an NCI-designated comprehensive cancer center: antioxidants and chemotherapeutic efficacy
Published in Cancer causes & control (01-03-2024)“…Purpose While community engagement has been a longstanding aspect of cancer-relevant research in social and behavioral sciences, it is far less common in…”
Get full text
Journal Article -
4
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia
Published in Leukemia (01-07-2021)“…Complex karyotype acute myeloid leukemia (CK-AML) has a dismal outcome with current treatments, underscoring the need for new therapies. Here, we report…”
Get full text
Journal Article -
5
Long-Acting E. coli-Derived Asparaginase Potentiates the Anti-Leukemic Effect of BCL2 Inhibition, but Not MCL1 Inhibition, in Preclinical Models of Acute Myeloid Leukemia
Published in Blood (02-11-2023)“…Background: Asparaginases are enzymes that deplete circulating asparagine and glutamine from plasma and can therefore be used therapeutically for cancers that…”
Get full text
Journal Article -
6
-
7
Abstract 4047: Pegcrisantaspase-based combination therapies for the treatment of pancreatic adenocarcinoma
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Pancreatic adenocarcinoma is one of the most aggressive human cancer types and is predicted to be the second leading cause of cancer-related deaths in…”
Get full text
Journal Article